Kamila Czubak-Prowizor

4PUBLICATIONS
0CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 08, 2022
Responses of human colon and breast adenocarcinoma cell lines (LoVo, MCF7) and non-tumorigenic mammary epithelial cells (MCF-10A) to the acellular fraction of packed red blood cells in the presence and absence of cisplatin.

Kamila Czubak-Prowizor, Anna Macieja, Tomasz Poplawski

|Mar 14, 2022
Packed Red Blood Cell Supernatants Do Not Promote Growth or Cisplatin Resistance of Myeloid Leukemia K-562 Cells.

Kamila Czubak-Prowizor, Anna Macieja, Tomasz Poplawski

|Sep 17, 2021
The F11 Receptor (F11R)/Junctional Adhesion Molecule-A (JAM-A) (F11R/JAM-A) in cancer progression.

Kamila Czubak-Prowizor, Anna Babinska, Maria Swiatkowska

|Apr 03, 2021
Increased Oxidative Stress in Acute Myeloid Leukemia Patients after Red Blood Cell Transfusion, but Not Platelet Transfusion, Results Mainly from the Oxidative/Nitrative Protein Damage: An Exploratory Study.

Kamila Czubak-Prowizor, Jacek Trelinski, Paulina Stelmach

Pageof 1

Frequent Collaborators